A nurse in a clinic is reviewing laboratory reports for a group of clients. Which of the following diseases should the nurse report to the state health department?

a. Including the time the medication error occurred is important for accurately documenting the sequence of events and providing context for further investigation or review.
b. Making a copy of the incident report for personal record-keeping may not be necessary as the incident report is typically filed in the institution's records system.
c. Identifying the medication name and dosage administered to the client is essential for understanding the nature and severity of the medication error and guiding subsequent actions or interventions.
d. Placing a copy of the completed report in the client's medical record, which is inappropriate because incident reports are internal documents and not part of the client's health record.
e. Obtaining an order from the client's provider to complete the report may not be necessary as incident reporting is typically a standard practice and does not require provider authorization.

a. A system for tracking client information: While important for managing patients during a disaster, it may not be the highest priority resource in response to a bioterrorism event where protection against exposure to hazardous materials is paramount.
b. A sufficient supply of personal protective equipment: In a bioterrorism event, such as exposure to biological agents, personal protective equipment (PPE) is critical to prevent the spread of pathogens and protect healthcare workers and patients from contamination.
c. A mental health specialist on the response team: Mental health support is important for both staff and patients during and after a disaster, but it may not be the highest priority resource in the immediate response to a bioterrorism event.
d. A network for communication between staff members and families: Communication is essential during any disaster response, but ensuring an adequate supply of personal protective equipment takes precedence in the face of potential exposure to biological agents.